Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients

Andrew T. Braun, Elliott C. Dasenbrook, Ashish S. Shah, Jonathan B Orens, Christian Merlo

Research output: Contribution to journalArticle

Abstract

Background The lung allocation score (LAS) has changed organ allocation for lung transplantation in the United States. Previous investigations of transplant recipients reported an association between high LAS and an increased risk of death after lung transplantation. We hypothesize that a high LAS predicts survival in lung transplant recipients with cystic fibrosis (CF) in the United Network for Organ Sharing Scientific Registry of Transplant Recipients database. Methods A cohort study was conducted of 1,437 U.S. adult lung transplant recipients with CF from May 1, 2005, through December 31, 2012. The cohort was divided into a high-risk group and a low-risk group based on LAS. Survival data were examined using Kaplan-Meier estimates and Cox proportional hazard models to compare survival. The primary outcome was adjusted survival at 1 year after lung transplantation. Results The high-risk group of 318 patients with a median LAS of 69.6 (interquartile range 56.3-87.2) was compared with a low-risk group of 1,119 patients with a median LAS of 38.8 (interquartile range 36.3-42.3). Patients in the high-risk group had a 41% increased relative risk of cumulative mortality at 1 year after transplantation compared with the low-risk group (16.1% vs 12.0%). After adjustment for known predictors of mortality, the risk of death at 1 year after transplantation remained elevated (hazard ratio = 1.41; 95% confidence interval = 1.00-2.01). The high-risk group had worse survival at 90 days and 2 years after lung transplantation. Conclusions High LAS are associated with worse survival in lung transplant recipients with CF.

Original languageEnglish (US)
Pages (from-to)1436-1441
Number of pages6
JournalJournal of Heart and Lung Transplantation
Volume34
Issue number11
DOIs
StatePublished - Nov 1 2015

Fingerprint

Cystic Fibrosis
Lung
Survival
Lung Transplantation
Transplantation
Transplant Recipients
Mortality
Kaplan-Meier Estimate
Proportional Hazards Models
Registries
Cohort Studies
Databases
Confidence Intervals

Keywords

  • cystic fibrosis
  • lung transplantation
  • mechanical ventilation
  • organ allocation
  • transplant candidacy

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients. / Braun, Andrew T.; Dasenbrook, Elliott C.; Shah, Ashish S.; Orens, Jonathan B; Merlo, Christian.

In: Journal of Heart and Lung Transplantation, Vol. 34, No. 11, 01.11.2015, p. 1436-1441.

Research output: Contribution to journalArticle

@article{768f2556b6f1462c9ee782684bf3a7a4,
title = "Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients",
abstract = "Background The lung allocation score (LAS) has changed organ allocation for lung transplantation in the United States. Previous investigations of transplant recipients reported an association between high LAS and an increased risk of death after lung transplantation. We hypothesize that a high LAS predicts survival in lung transplant recipients with cystic fibrosis (CF) in the United Network for Organ Sharing Scientific Registry of Transplant Recipients database. Methods A cohort study was conducted of 1,437 U.S. adult lung transplant recipients with CF from May 1, 2005, through December 31, 2012. The cohort was divided into a high-risk group and a low-risk group based on LAS. Survival data were examined using Kaplan-Meier estimates and Cox proportional hazard models to compare survival. The primary outcome was adjusted survival at 1 year after lung transplantation. Results The high-risk group of 318 patients with a median LAS of 69.6 (interquartile range 56.3-87.2) was compared with a low-risk group of 1,119 patients with a median LAS of 38.8 (interquartile range 36.3-42.3). Patients in the high-risk group had a 41{\%} increased relative risk of cumulative mortality at 1 year after transplantation compared with the low-risk group (16.1{\%} vs 12.0{\%}). After adjustment for known predictors of mortality, the risk of death at 1 year after transplantation remained elevated (hazard ratio = 1.41; 95{\%} confidence interval = 1.00-2.01). The high-risk group had worse survival at 90 days and 2 years after lung transplantation. Conclusions High LAS are associated with worse survival in lung transplant recipients with CF.",
keywords = "cystic fibrosis, lung transplantation, mechanical ventilation, organ allocation, transplant candidacy",
author = "Braun, {Andrew T.} and Dasenbrook, {Elliott C.} and Shah, {Ashish S.} and Orens, {Jonathan B} and Christian Merlo",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.healun.2015.05.020",
language = "English (US)",
volume = "34",
pages = "1436--1441",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "11",

}

TY - JOUR

T1 - Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients

AU - Braun, Andrew T.

AU - Dasenbrook, Elliott C.

AU - Shah, Ashish S.

AU - Orens, Jonathan B

AU - Merlo, Christian

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background The lung allocation score (LAS) has changed organ allocation for lung transplantation in the United States. Previous investigations of transplant recipients reported an association between high LAS and an increased risk of death after lung transplantation. We hypothesize that a high LAS predicts survival in lung transplant recipients with cystic fibrosis (CF) in the United Network for Organ Sharing Scientific Registry of Transplant Recipients database. Methods A cohort study was conducted of 1,437 U.S. adult lung transplant recipients with CF from May 1, 2005, through December 31, 2012. The cohort was divided into a high-risk group and a low-risk group based on LAS. Survival data were examined using Kaplan-Meier estimates and Cox proportional hazard models to compare survival. The primary outcome was adjusted survival at 1 year after lung transplantation. Results The high-risk group of 318 patients with a median LAS of 69.6 (interquartile range 56.3-87.2) was compared with a low-risk group of 1,119 patients with a median LAS of 38.8 (interquartile range 36.3-42.3). Patients in the high-risk group had a 41% increased relative risk of cumulative mortality at 1 year after transplantation compared with the low-risk group (16.1% vs 12.0%). After adjustment for known predictors of mortality, the risk of death at 1 year after transplantation remained elevated (hazard ratio = 1.41; 95% confidence interval = 1.00-2.01). The high-risk group had worse survival at 90 days and 2 years after lung transplantation. Conclusions High LAS are associated with worse survival in lung transplant recipients with CF.

AB - Background The lung allocation score (LAS) has changed organ allocation for lung transplantation in the United States. Previous investigations of transplant recipients reported an association between high LAS and an increased risk of death after lung transplantation. We hypothesize that a high LAS predicts survival in lung transplant recipients with cystic fibrosis (CF) in the United Network for Organ Sharing Scientific Registry of Transplant Recipients database. Methods A cohort study was conducted of 1,437 U.S. adult lung transplant recipients with CF from May 1, 2005, through December 31, 2012. The cohort was divided into a high-risk group and a low-risk group based on LAS. Survival data were examined using Kaplan-Meier estimates and Cox proportional hazard models to compare survival. The primary outcome was adjusted survival at 1 year after lung transplantation. Results The high-risk group of 318 patients with a median LAS of 69.6 (interquartile range 56.3-87.2) was compared with a low-risk group of 1,119 patients with a median LAS of 38.8 (interquartile range 36.3-42.3). Patients in the high-risk group had a 41% increased relative risk of cumulative mortality at 1 year after transplantation compared with the low-risk group (16.1% vs 12.0%). After adjustment for known predictors of mortality, the risk of death at 1 year after transplantation remained elevated (hazard ratio = 1.41; 95% confidence interval = 1.00-2.01). The high-risk group had worse survival at 90 days and 2 years after lung transplantation. Conclusions High LAS are associated with worse survival in lung transplant recipients with CF.

KW - cystic fibrosis

KW - lung transplantation

KW - mechanical ventilation

KW - organ allocation

KW - transplant candidacy

UR - http://www.scopus.com/inward/record.url?scp=84946481915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946481915&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2015.05.020

DO - 10.1016/j.healun.2015.05.020

M3 - Article

VL - 34

SP - 1436

EP - 1441

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 11

ER -